drugset / Trial / NCT00956150

Bacterial Overgrowth Associated With Chronic Multisymptom Illness Complex

NCT00956150

Phase 1 Unknown 210 enrolled Henry C. Lin, MD
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The adverse impact of Gulf War Syndrome (GWS) on the health of veterans and on the resources of the VA Healthcare System underscores the need to resolve its underlying cause. In response, the investigators propose to investigate the central hypothesis that gut bacteria may be responsible for symptoms associated with GWS. The investigators will enroll a total of 120 patients with GWS and 90 healthy controls.

Timeline

Start
2009-04
Primary completion
2014-03
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rifaximin Other / unclassified 600 mg Oral

Indications